Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience

Figure 3

Male, 73 year old, pancreas NET with liver metastases. ⁶⁸Ga-DOTATOC PET/CT before (left) and after therapy (right). PRRT with ⁹⁰Y-DOTATOC (2 cycles) and ¹⁷⁷Lu-DOTATOC (4 cycles) was administered at interval of 2 months. The response was complete in the liver but partial in the pancreatics region (arrow).

(a)

(b)